Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...
Benzinga.com4d
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham initiates Absci coverage with a Buy rating and a $9 price target, citing robust proprietary technology. Absci’s partnerships with Merck, AstraZeneca, and Almirall provide milestone ...
Absci shares jump as analyst lauds 'practical' AI drug company
"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...
Top 10 Medical AI Stocks on Wall Street’s Radar
According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...
Needham initiates Absci shares with Buy rating on strategy
Absci Corp. (NASDAQ:ABSI) shares, currently trading at $3.22, received a positive outlook from Needham as the firm began coverage with a Buy rating and set a price target of $9.00. The stock has shown ...
bovnews3d
Absci Corp (ABSI) Stock: Understanding Its Underlying Value
Needham has recently initiated Absci Corp (ABSI) stock to Buy rating, as announced on Today, according to Finviz. Earlier, on October 2, 2024, Guggenheim had initiated the stock to Buy, setting a ...
bovnews5d
What’s Fueling Absci Corp (ABSI) Stock’s -26.93% Loss Below Its 200-Day SMA?
Guggenheim has recently initiated Absci Corp (ABSI) stock to Buy rating, as announced on October 2, 2024, according to Finviz. Earlier, on July 3, 2024, Morgan Stanley had initiated the stock to ...